Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts.
Identifieur interne : 003430 ( PubMed/Curation ); précédent : 003429; suivant : 003431Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts.
Auteurs : M. Aljurf ; J D Rizzo [États-Unis] ; M. Mohty [France] ; F. Hussain ; A. Madrigal [Royaume-Uni] ; M C Pasquini [États-Unis] ; J. Passweg [Allemagne] ; N. Chaudhri ; A. Ghavamzadeh [Iran] ; H E Solh ; Y. Atsuta [Japon] ; J. Szer [Australie] ; Y. Kodera [Japon] ; D. Niederweiser [Allemagne] ; A. Gratwohl [Suisse] ; M M Horowitz [États-Unis]Source :
- Bone marrow transplantation [ 1476-5365 ] ; 2014.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
Abstract
Patient registries, frequently referred to as outcome registries, are 'organized systems' that use observational study methods to collect uniform data. Registries are used to evaluate specified outcomes for a population defined by a particular disease, condition or exposure that serves one or more predetermined scientific, clinical or policy purposes. Outcome registries were established very early in the development of hematopoietic SCT (HSCT). Currently, myriads of national and international HSCT registries collect information about HSCT activities and outcomes. These registries have contributed significantly to determining trends, patterns, treatment practices and outcomes. There are many different HSCT registries, each with different aims and goals; some are led by professional organizations, others by government authorities, health care providers or third parties. Some registries simply assess activity and others study outcomes. These registries are complementary and are gradually developing interoperability with each other to expand future collaborative research activities. A key development in the last few years was the incorporation of recommendations into the World Health Organization guiding principles on cell, tissue and organ transplantation. The data collection and analysis should be an integral part of therapy and an obligation rather than a choice for transplant programs. This article examines challenges in ensuring data quality and functions of outcome registries, using HSCT registries as an example. It applies to all HSCT-related data, but is predominantly focused on HSCT registries of professional organizations.
DOI: 10.1038/bmt.2014.78
PubMed: 24777183
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003543
Links to Exploration step
pubmed:24777183Curation
No country items
M. Aljurf<affiliation><nlm:affiliation>Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation><wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation><wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation><wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation><wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry></affiliation>Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts.</title><author><name sortKey="Aljurf, M" sort="Aljurf, M" uniqKey="Aljurf M" first="M" last="Aljurf">M. Aljurf</name><affiliation><nlm:affiliation>Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation><wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry></affiliation></author><author><name sortKey="Rizzo, J D" sort="Rizzo, J D" uniqKey="Rizzo J" first="J D" last="Rizzo">J D Rizzo</name><affiliation wicri:level="1"><nlm:affiliation>Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for International Blood and Marrow Transplant Research, Milwaukee, WI</wicri:regionArea></affiliation></author><author><name sortKey="Mohty, M" sort="Mohty, M" uniqKey="Mohty M" first="M" last="Mohty">M. Mohty</name><affiliation wicri:level="1"><nlm:affiliation>Hematology Department, Saint-Antoine Hospital, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hematology Department, Saint-Antoine Hospital, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Hussain, F" sort="Hussain, F" uniqKey="Hussain F" first="F" last="Hussain">F. Hussain</name><affiliation><nlm:affiliation>Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation><wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry></affiliation></author><author><name sortKey="Madrigal, A" sort="Madrigal, A" uniqKey="Madrigal A" first="A" last="Madrigal">A. Madrigal</name><affiliation wicri:level="1"><nlm:affiliation>The Royal Free and University College Medical School, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>The Royal Free and University College Medical School, London</wicri:regionArea></affiliation></author><author><name sortKey="Pasquini, M C" sort="Pasquini, M C" uniqKey="Pasquini M" first="M C" last="Pasquini">M C Pasquini</name><affiliation wicri:level="1"><nlm:affiliation>Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for International Blood and Marrow Transplant Research, Milwaukee, WI</wicri:regionArea></affiliation></author><author><name sortKey="Passweg, J" sort="Passweg, J" uniqKey="Passweg J" first="J" last="Passweg">J. Passweg</name><affiliation wicri:level="1"><nlm:affiliation>University of Leipzig, Leipzig, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>University of Leipzig, Leipzig</wicri:regionArea></affiliation></author><author><name sortKey="Chaudhri, N" sort="Chaudhri, N" uniqKey="Chaudhri N" first="N" last="Chaudhri">N. Chaudhri</name><affiliation><nlm:affiliation>Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation><wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry></affiliation></author><author><name sortKey="Ghavamzadeh, A" sort="Ghavamzadeh, A" uniqKey="Ghavamzadeh A" first="A" last="Ghavamzadeh">A. Ghavamzadeh</name><affiliation wicri:level="1"><nlm:affiliation>Tehran University of Medical Sciences, Hematology, Oncology and SCT Research Center, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Tehran University of Medical Sciences, Hematology, Oncology and SCT Research Center, Tehran</wicri:regionArea></affiliation></author><author><name sortKey="Solh, H E" sort="Solh, H E" uniqKey="Solh H" first="H E" last="Solh">H E Solh</name><affiliation><nlm:affiliation>Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation><wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry></affiliation></author><author><name sortKey="Atsuta, Y" sort="Atsuta, Y" uniqKey="Atsuta Y" first="Y" last="Atsuta">Y. Atsuta</name><affiliation wicri:level="1"><nlm:affiliation>Nagoya University Graduate School of Medicine, Nagoya, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Nagoya University Graduate School of Medicine, Nagoya</wicri:regionArea></affiliation></author><author><name sortKey="Szer, J" sort="Szer, J" uniqKey="Szer J" first="J" last="Szer">J. Szer</name><affiliation wicri:level="1"><nlm:affiliation>The Royal Melbourne Hospital, Parkville, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The Royal Melbourne Hospital, Parkville</wicri:regionArea></affiliation></author><author><name sortKey="Kodera, Y" sort="Kodera, Y" uniqKey="Kodera Y" first="Y" last="Kodera">Y. Kodera</name><affiliation wicri:level="1"><nlm:affiliation>Aichi Medical University School of Medicine, Aichi, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Aichi Medical University School of Medicine, Aichi</wicri:regionArea></affiliation></author><author><name sortKey="Niederweiser, D" sort="Niederweiser, D" uniqKey="Niederweiser D" first="D" last="Niederweiser">D. Niederweiser</name><affiliation wicri:level="1"><nlm:affiliation>University of Leipzig, Leipzig, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>University of Leipzig, Leipzig</wicri:regionArea></affiliation></author><author><name sortKey="Gratwohl, A" sort="Gratwohl, A" uniqKey="Gratwohl A" first="A" last="Gratwohl">A. Gratwohl</name><affiliation wicri:level="1"><nlm:affiliation>University Hospital of Basel, Basel, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>University Hospital of Basel, Basel</wicri:regionArea></affiliation></author><author><name sortKey="Horowitz, M M" sort="Horowitz, M M" uniqKey="Horowitz M" first="M M" last="Horowitz">M M Horowitz</name><affiliation wicri:level="1"><nlm:affiliation>Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for International Blood and Marrow Transplant Research, Milwaukee, WI</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24777183</idno><idno type="pmid">24777183</idno><idno type="doi">10.1038/bmt.2014.78</idno><idno type="wicri:Area/PubMed/Corpus">003543</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003543</idno><idno type="wicri:Area/PubMed/Curation">003430</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003430</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts.</title><author><name sortKey="Aljurf, M" sort="Aljurf, M" uniqKey="Aljurf M" first="M" last="Aljurf">M. Aljurf</name><affiliation><nlm:affiliation>Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation><wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry></affiliation></author><author><name sortKey="Rizzo, J D" sort="Rizzo, J D" uniqKey="Rizzo J" first="J D" last="Rizzo">J D Rizzo</name><affiliation wicri:level="1"><nlm:affiliation>Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for International Blood and Marrow Transplant Research, Milwaukee, WI</wicri:regionArea></affiliation></author><author><name sortKey="Mohty, M" sort="Mohty, M" uniqKey="Mohty M" first="M" last="Mohty">M. Mohty</name><affiliation wicri:level="1"><nlm:affiliation>Hematology Department, Saint-Antoine Hospital, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hematology Department, Saint-Antoine Hospital, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Hussain, F" sort="Hussain, F" uniqKey="Hussain F" first="F" last="Hussain">F. Hussain</name><affiliation><nlm:affiliation>Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation><wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry></affiliation></author><author><name sortKey="Madrigal, A" sort="Madrigal, A" uniqKey="Madrigal A" first="A" last="Madrigal">A. Madrigal</name><affiliation wicri:level="1"><nlm:affiliation>The Royal Free and University College Medical School, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>The Royal Free and University College Medical School, London</wicri:regionArea></affiliation></author><author><name sortKey="Pasquini, M C" sort="Pasquini, M C" uniqKey="Pasquini M" first="M C" last="Pasquini">M C Pasquini</name><affiliation wicri:level="1"><nlm:affiliation>Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for International Blood and Marrow Transplant Research, Milwaukee, WI</wicri:regionArea></affiliation></author><author><name sortKey="Passweg, J" sort="Passweg, J" uniqKey="Passweg J" first="J" last="Passweg">J. Passweg</name><affiliation wicri:level="1"><nlm:affiliation>University of Leipzig, Leipzig, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>University of Leipzig, Leipzig</wicri:regionArea></affiliation></author><author><name sortKey="Chaudhri, N" sort="Chaudhri, N" uniqKey="Chaudhri N" first="N" last="Chaudhri">N. Chaudhri</name><affiliation><nlm:affiliation>Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation><wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry></affiliation></author><author><name sortKey="Ghavamzadeh, A" sort="Ghavamzadeh, A" uniqKey="Ghavamzadeh A" first="A" last="Ghavamzadeh">A. Ghavamzadeh</name><affiliation wicri:level="1"><nlm:affiliation>Tehran University of Medical Sciences, Hematology, Oncology and SCT Research Center, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Tehran University of Medical Sciences, Hematology, Oncology and SCT Research Center, Tehran</wicri:regionArea></affiliation></author><author><name sortKey="Solh, H E" sort="Solh, H E" uniqKey="Solh H" first="H E" last="Solh">H E Solh</name><affiliation><nlm:affiliation>Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation><wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry></affiliation></author><author><name sortKey="Atsuta, Y" sort="Atsuta, Y" uniqKey="Atsuta Y" first="Y" last="Atsuta">Y. Atsuta</name><affiliation wicri:level="1"><nlm:affiliation>Nagoya University Graduate School of Medicine, Nagoya, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Nagoya University Graduate School of Medicine, Nagoya</wicri:regionArea></affiliation></author><author><name sortKey="Szer, J" sort="Szer, J" uniqKey="Szer J" first="J" last="Szer">J. Szer</name><affiliation wicri:level="1"><nlm:affiliation>The Royal Melbourne Hospital, Parkville, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The Royal Melbourne Hospital, Parkville</wicri:regionArea></affiliation></author><author><name sortKey="Kodera, Y" sort="Kodera, Y" uniqKey="Kodera Y" first="Y" last="Kodera">Y. Kodera</name><affiliation wicri:level="1"><nlm:affiliation>Aichi Medical University School of Medicine, Aichi, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Aichi Medical University School of Medicine, Aichi</wicri:regionArea></affiliation></author><author><name sortKey="Niederweiser, D" sort="Niederweiser, D" uniqKey="Niederweiser D" first="D" last="Niederweiser">D. Niederweiser</name><affiliation wicri:level="1"><nlm:affiliation>University of Leipzig, Leipzig, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>University of Leipzig, Leipzig</wicri:regionArea></affiliation></author><author><name sortKey="Gratwohl, A" sort="Gratwohl, A" uniqKey="Gratwohl A" first="A" last="Gratwohl">A. Gratwohl</name><affiliation wicri:level="1"><nlm:affiliation>University Hospital of Basel, Basel, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>University Hospital of Basel, Basel</wicri:regionArea></affiliation></author><author><name sortKey="Horowitz, M M" sort="Horowitz, M M" uniqKey="Horowitz M" first="M M" last="Horowitz">M M Horowitz</name><affiliation wicri:level="1"><nlm:affiliation>Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for International Blood and Marrow Transplant Research, Milwaukee, WI</wicri:regionArea></affiliation></author></analytic><series><title level="j">Bone marrow transplantation</title><idno type="eISSN">1476-5365</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Hematopoietic Stem Cell Transplantation</term><term>Humans</term><term>Multicenter Studies as Topic</term><term>Registries</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Enregistrements</term><term>Humains</term><term>Transplantation de cellules souches hématopoïétiques</term><term>Études multicentriques comme sujet</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Hematopoietic Stem Cell Transplantation</term><term>Humans</term><term>Multicenter Studies as Topic</term><term>Registries</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Enregistrements</term><term>Humains</term><term>Transplantation de cellules souches hématopoïétiques</term><term>Études multicentriques comme sujet</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Patient registries, frequently referred to as outcome registries, are 'organized systems' that use observational study methods to collect uniform data. Registries are used to evaluate specified outcomes for a population defined by a particular disease, condition or exposure that serves one or more predetermined scientific, clinical or policy purposes. Outcome registries were established very early in the development of hematopoietic SCT (HSCT). Currently, myriads of national and international HSCT registries collect information about HSCT activities and outcomes. These registries have contributed significantly to determining trends, patterns, treatment practices and outcomes. There are many different HSCT registries, each with different aims and goals; some are led by professional organizations, others by government authorities, health care providers or third parties. Some registries simply assess activity and others study outcomes. These registries are complementary and are gradually developing interoperability with each other to expand future collaborative research activities. A key development in the last few years was the incorporation of recommendations into the World Health Organization guiding principles on cell, tissue and organ transplantation. The data collection and analysis should be an integral part of therapy and an obligation rather than a choice for transplant programs. This article examines challenges in ensuring data quality and functions of outcome registries, using HSCT registries as an example. It applies to all HSCT-related data, but is predominantly focused on HSCT registries of professional organizations.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24777183</PMID><DateCreated><Year>2014</Year><Month>08</Month><Day>06</Day></DateCreated><DateCompleted><Year>2015</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5365</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>8</Issue><PubDate><Year>2014</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Bone marrow transplantation</Title><ISOAbbreviation>Bone Marrow Transplant.</ISOAbbreviation></Journal><ArticleTitle>Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts.</ArticleTitle><Pagination><MedlinePgn>1016-21</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/bmt.2014.78</ELocationID><Abstract><AbstractText>Patient registries, frequently referred to as outcome registries, are 'organized systems' that use observational study methods to collect uniform data. Registries are used to evaluate specified outcomes for a population defined by a particular disease, condition or exposure that serves one or more predetermined scientific, clinical or policy purposes. Outcome registries were established very early in the development of hematopoietic SCT (HSCT). Currently, myriads of national and international HSCT registries collect information about HSCT activities and outcomes. These registries have contributed significantly to determining trends, patterns, treatment practices and outcomes. There are many different HSCT registries, each with different aims and goals; some are led by professional organizations, others by government authorities, health care providers or third parties. Some registries simply assess activity and others study outcomes. These registries are complementary and are gradually developing interoperability with each other to expand future collaborative research activities. A key development in the last few years was the incorporation of recommendations into the World Health Organization guiding principles on cell, tissue and organ transplantation. The data collection and analysis should be an integral part of therapy and an obligation rather than a choice for transplant programs. This article examines challenges in ensuring data quality and functions of outcome registries, using HSCT registries as an example. It applies to all HSCT-related data, but is predominantly focused on HSCT registries of professional organizations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aljurf</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzo</LastName><ForeName>J D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohty</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hematology Department, Saint-Antoine Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussain</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madrigal</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Royal Free and University College Medical School, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasquini</LastName><ForeName>M C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Passweg</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhri</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghavamzadeh</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tehran University of Medical Sciences, Hematology, Oncology and SCT Research Center, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solh</LastName><ForeName>H E</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atsuta</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szer</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Royal Melbourne Hospital, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kodera</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Aichi Medical University School of Medicine, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niederweiser</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gratwohl</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horowitz</LastName><ForeName>M M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Bone Marrow Transplant</MedlineTA><NlmUniqueID>8702459</NlmUniqueID><ISSNLinking>0268-3369</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2010 Apr 28;303(16):1617-24</RefSource><PMID Version="1">20424252</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2013 Sep 19;122(12):2135-41</RefSource><PMID Version="1">23926304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S1-S2</RefSource><PMID Version="1">18724277</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2010 Jul;11(7):653-60</RefSource><PMID Version="1">20558104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Blood Marrow Transplant. 2011 Sep;17(9):1375-82</RefSource><PMID Version="1">21277376</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Blood Marrow Transplant. 1999;5(3):180-6</RefSource><PMID Version="1">10392964</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Hematol. 2007 Oct;86(3):269-74</RefSource><PMID Version="1">17988995</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Blood Marrow Transplant. 2005 Dec;11(12):945-56</RefSource><PMID Version="1">16338616</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 1992 Aug 5;268(5):607-12</RefSource><PMID Version="1">1321298</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Blood Marrow Transplant. 2010 Aug;16(8):1076-83</RefSource><PMID Version="1">20304084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2009 Jan 29;113(5):1175-83</RefSource><PMID Version="1">18971419</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1994 Oct 20;331(16):1063-7</RefSource><PMID Version="1">8090167</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2011 Oct 20;118(16):4472-9</RefSource><PMID Version="1">21878671</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bone Marrow Transplant. 2001 Apr;27(7):689-92</RefSource><PMID Version="1">11360107</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Blood Marrow Transplant. 2013 Nov;19(11):1600-7</RefSource><PMID Version="1">24018394</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2014 Jan 2;123(1):133-40</RefSource><PMID Version="1">24141369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S6</RefSource><PMID Version="1">18724304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Haematol. 2004 Feb;124(4):499-503</RefSource><PMID Version="1">14984501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1988 Oct;6(10):1562-8</RefSource><PMID Version="1">3049951</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D018380" MajorTopicYN="Y">Hematopoietic Stem Cell Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="Y">Registries</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>02</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>03</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>03</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24777183</ArticleId><ArticleId IdType="pii">bmt201478</ArticleId><ArticleId IdType="doi">10.1038/bmt.2014.78</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003430 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003430 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:24777183
|texte= Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:24777183" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |